JACQUELINE THIGPEN: Open Payments
NPI 1417592288 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,772 in 115 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $257 · 2025 $2,772
Food & beverage: $2,695Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $889 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $324 |
| ABBVIE INC. | 14 | $250 |
| Madrigal Pharmaceuticals | 6 | $232 |
| Ardelyx, Inc. | 13 | $217 |
| Regeneron Healthcare Solutions, Inc. | 5 | $192 |
| Aimmune Therapeutics, Inc. | 9 | $180 |
| PFIZER INC. | 5 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $92 |
| Gilead Sciences, Inc. | 2 | $51 |
Products named: TREMFYA, XIFAXAN, REZDIFFRA, IBSRELA, ZENPEP, CREON, RINVOQ, ENTYVIO.
Industry payments across NC — which companies pay providers there.
